scholarly journals Phase II studies of Elsamitrucin in breast cancer, colorectal cancer, non-small cell lung cancer and ovarian cancer

1994 ◽  
Vol 5 (4) ◽  
pp. 375-376 ◽  
Author(s):  
J. Verweij ◽  
J. Wanders ◽  
A.L. Nielsen ◽  
N. Pavlidis ◽  
F. Calabresi ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Colorectal Cancer ◽  
Lung Cancer ◽  
Ovarian Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cancer Colorectal ◽  
Small Cell ◽  
Small Cell Lung ◽  
Phase Ii Studies

Suramin in Non-small Cell Lung Cancer and Advanced Breast Cancer: Two Parallel Phase II Studies

1997 ◽  
Vol 36 (2) ◽  
pp. 171-174 ◽  
Author(s):  
Mansoor R. Mirza ◽  
Erik Jakobsen ◽  
Per Pfeiffer ◽  
Bente Lindebjerg-Clasen ◽  
Jonas Bergh ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Advanced Breast Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Advanced Breast ◽  
Small Cell Lung ◽  
Phase Ii Studies

scholarly journals Pegfilgrastim on the Same Day Versus Next Day of Chemotherapy in Patients With Breast Cancer, Non–Small-Cell Lung Cancer, Ovarian Cancer, and Non-Hodgkin's Lymphoma: Results of Four Multicenter, Double-Blind, Randomized Phase II Studies

2010 ◽  
Vol 6 (3) ◽  
pp. 133-140 ◽  
Author(s):  
Howard A. Burris ◽  
Chandra P. Belani ◽  
Peter A. Kaufman ◽  
Alan N. Gordon ◽  
Lee S. Schwartzberg ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Lung Cancer ◽  
Ovarian Cancer ◽  
Small Cell Lung Cancer ◽  
Small Cell ◽  
Small Cell Lung ◽  
Double Blind ◽  
Safety And Efficacy ◽  
Phase Ii Studies ◽  
Randomized Phase Ii

Four tumor-specific studies were designed to assess the safety and efficacy of pegfilgrastim administered concurrently with chemotherapy.

Pooled overall survival and safety data from the pivotal phase II studies (NP28673 and NP28761) of alectinib in ALK-positive non-small cell lung cancer (NSCLC).

2018 ◽  
Vol 36 (15_suppl) ◽  
pp. 9072-9072 ◽  
Author(s):  
Sai-Hong Ignatius Ou ◽  
Leena Gandhi ◽  
Shirish M. Gadgeel ◽  
Fabrice Barlesi ◽  
James Chih-Hsin Yang ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Overall Survival ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Safety Data ◽  
Small Cell ◽  
Small Cell Lung ◽  
Pivotal Phase ◽  
Phase Ii Studies ◽  
Alk Positive

Pooled overall survival and safety data from the pivotal phase II studies (NP28673 and NP28761) of alectinib in ALK-positive non-small-cell lung cancer

Lung Cancer ◽  
2020 ◽  
Vol 139 ◽  
pp. 22-27 ◽  
Author(s):  
Sai-Hong Ignatius Ou ◽  
Shirish M. Gadgeel ◽  
Fabrice Barlesi ◽  
James Chih-Hsin Yang ◽  
Luigi De Petris ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Overall Survival ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Safety Data ◽  
Small Cell ◽  
Small Cell Lung ◽  
Pivotal Phase ◽  
Phase Ii Studies ◽  
Alk Positive
Sign in / Sign up

Export Citation Format

Share Document